INTRACRANIAL ARTERIOSCLEROSIS
Clinical trials for INTRACRANIAL ARTERIOSCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new INTRACRANIAL ARTERIOSCLEROSIS trials appear
Sign up with your email to follow new studies for INTRACRANIAL ARTERIOSCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New blood thinner cocktails aim to outsmart stroke in High-Risk patients
Disease control OngoingThis large phase 3 trial tests whether newer blood thinner combinations (ticagrelor plus aspirin or rivaroxaban plus aspirin) are better than the standard clopidogrel plus aspirin at preventing stroke, brain bleeding, or death from blood vessel disease. Over 1,600 participants wi…
Matched conditions: INTRACRANIAL ARTERIOSCLEROSIS
Phase: PHASE3 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 02, 2026 01:00 UTC
-
Brain stent blood thinner study pulled before it began
Disease control TerminatedThis study planned to compare taking blood thinners for 3 months versus 6 months after placing a special drug-coated stent in a narrowed brain artery. The goal was to see if the shorter treatment was just as good at preventing strokes and bleeding. However, the trial was withdraw…
Matched conditions: INTRACRANIAL ARTERIOSCLEROSIS
Phase: NA • Sponsor: Sino Medical Sciences Technology Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC